Illinois Attorney General Lisa Madigan has reached a $4.5 million settlement with an Arizona-based pharmaceutical company that her office sued for deceptive marketing of an opioid drug meant for cancer patients.
Madigan said Insys Therapeutics Inc. “pushed a highly addictive opioid in complete disregard for patients’ health to increase company profits.”
The lawsuit she filed last year accused Insys of selling Subsys, a drug significantly more powerful than morphine, to treat a wide variety of pain such as back and neck pain. The drug was not approved for those uses.
Insys officials didn’t respond to phone messages left by the Associated Press at the company’s Phoenix-area office. The company has previously said the marketing of Subsys was appropriate.
Madigan says the $4.5 million will fund drug treatment programs.
Topics Illinois
Was this article valuable?
Here are more articles you may enjoy.
AIG Partners With Amwins, Blackstone to Launch Lloyd’s Syndicate Using Palantir
Twice Injured Firefighter Loses Second Workers’ Compensation Claim
Head of EEOC Urges White Men to Report Discrimination
‘Door Knocker’ Roofers Were Everywhere. NC Farm Bureau Saw an Opportunity 

